Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06592378 · ClinicalTrials.gov registry record · NA
Opioid Management for Discharged Emergency Department Patients
A NA study of Bone Fractures, sponsored by Addinex Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06592378: Recruiting NA study of Bone Fractures, sponsored by Addinex Technologies.
NCT06592378 is a NA study of Bone Fractures that is actively recruiting participants, run by Addinex Technologies. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06592378, a NA study of Bone Fractures, is actively recruiting participants, sponsored by Addinex Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.
Primary Outcome
Patients are expected to consume at least 16% fewer pills/MMEs using the Addinex system as compared to the control group.
Conditions Studied
Interventions
- DEVICE Addinex
- DEVICE Standard Pill Bottle
Study Locations (1)
Rhode Island
- Rhode Island Hospital/Lifespan - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-27 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT06592378 shows while recruiting
NCT06592378 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Bone Fractures appearing as the primary indexed condition, and to 2 interventions - of which Addinex is the first listed.
NCT06592378 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06592378 about?
NCT06592378 is a clinical study titled "Opioid Management for Discharged Emergency Department Patients". The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to ...
What is the current status of trial NCT06592378?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-27. Estimated completion is 2026-06-30.
What conditions does trial NCT06592378 study?
This clinical trial studies the following conditions: Bone Fractures.
What interventions are being tested in trial NCT06592378?
The interventions under investigation include: Addinex (DEVICE), Standard Pill Bottle (DEVICE).
Who is sponsoring clinical trial NCT06592378?
This trial is sponsored by Addinex Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06592378 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06592378's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI